c-Jun N-terminal kinase (JNK) signaling contributes to cystic burden in polycystic kidney disease
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
c-Jun N-terminal kinase (JNK) signaling contributes to cystic burden in polycystic kidney disease
Authors
Keywords
Kidneys, c-Jun N-terminal kinase signaling cascade, Mouse models, Fibrosis, Weight loss, Phosphorylation, Immunoblotting, Polycystic kidney disease
Journal
PLoS Genetics
Volume 17, Issue 12, Pages e1009711
Publisher
Public Library of Science (PLoS)
Online
2021-12-29
DOI
10.1371/journal.pgen.1009711
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- JNK signaling as a target for anticancer therapy
- (2021) Kamal S. Abdelrahman et al. Pharmacological Reports
- JNK signaling prevents biliary cyst formation through a CASPASE-8–dependent function of RIPK1 during aging
- (2021) Katrin Müller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective inhibitors for JNK signalling: a potential targeted therapy in cancer
- (2020) Qinghua Wu et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- JNK-mediated disruption of bile acid homeostasis promotes intrahepatic cholangiocarcinoma
- (2020) Elisa Manieri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- JNK signaling in cancer cell survival
- (2019) Qinghua Wu et al. MEDICINAL RESEARCH REVIEWS
- A Mutation Affecting Polycystin-1 Mediated Heterotrimeric G-Protein Signaling Causes PKD
- (2018) Stephen C Parnell et al. HUMAN MOLECULAR GENETICS
- URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer’s disease
- (2018) Tomomi Kiyota et al. Journal of Neuroinflammation
- Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib
- (2018) Zobair M. Younossi et al. LIVER INTERNATIONAL
- A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan
- (2018) Fouad T. Chebib et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- C-MYC is a regulator ofthe PKD1 gene and PC1-induced pathogenesis
- (2018) Camila Parrot et al. HUMAN MOLECULAR GENETICS
- The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
- (2017) Rohit Loomba et al. HEPATOLOGY
- Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
- (2017) Vicente E. Torres et al. NEW ENGLAND JOURNAL OF MEDICINE
- Unifying mechanism for different fibrotic diseases
- (2017) Gerlinde Wernig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial
- (2016) V. E. Torres et al. Clinical Journal of the American Society of Nephrology
- The mixed-lineage kinase 3 inhibitor URMC-099 facilitates microglial amyloid-β degradation
- (2016) Weiguo Dong et al. Journal of Neuroinflammation
- The polycystin complex mediates Wnt/Ca2+ signalling
- (2016) Seokho Kim et al. NATURE CELL BIOLOGY
- An alternative splicing program promotes adipose tissue thermogenesis
- (2016) Santiago Vernia et al. eLife
- The phosphatidylinositol 3-kinase/Akt and c-Jun N-terminal kinase signaling in cancer: Alliance or contradiction? (Review)
- (2015) HUA-FU ZHAO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- JNK signalling in cancer: in need of new, smarter therapeutic targets
- (2013) Concetta Bubici et al. BRITISH JOURNAL OF PHARMACOLOGY
- Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease
- (2013) Ming Ma et al. NATURE GENETICS
- Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease
- (2012) Tom JG Gevers et al. BMC Nephrology
- Evaluation of JNK Blockade as an Early Intervention Treatment for Type 1 Diabetic Nephropathy in Hypertensive Rats
- (2011) Andy K.H. Lim et al. AMERICAN JOURNAL OF NEPHROLOGY
- TNF-stimulated MAP kinase activation mediated by a Rho family GTPase signaling pathway
- (2011) S. Kant et al. GENES & DEVELOPMENT
- Polycystin-1 Protein Level Determines Activity of the Gα12/JNK Apoptosis Pathway
- (2010) Wanfeng Yu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- JNK signalling in human and experimental renal ischaemia/reperfusion injury
- (2010) J. Kanellis et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Pkd1 and Pkd2 Are Required for Normal Placental Development
- (2010) Miguel A. Garcia-Gonzalez et al. PLoS One
- Pkd2 Dosage Influences Cellular Repair Responses following Ischemia-Reperfusion Injury
- (2009) Sony Prasad et al. AMERICAN JOURNAL OF PATHOLOGY
- Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways
- (2009) H. Happe et al. HUMAN MOLECULAR GENETICS
- c-Jun NH2-Terminal Kinase Is Crucially Involved in Renal Tubulo-Interstitial Inflammation
- (2009) M. H. de Borst et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Blockade of the c-Jun amino terminal kinase prevents crescent formation and halts established anti-GBM glomerulonephritis in the rat
- (2009) Frank Y Ma et al. LABORATORY INVESTIGATION
- Cre recombinase activity specific to postnatal, premeiotic male germ cells in transgenic mice
- (2008) Patricia I. Sadate-Ngatchou et al. GENESIS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now